Framing vaccines as an infringement of liberty is a powerful tactic, but obscures health and political factors that may actually drive resistance.
Academic rigour, journalistic flair
Articles on COVID-19
Displaying 1001 - 1020 of 7945 articles
Just as access to vaccines was vastly more difficult for low-income countries, the same is now true for the virus’ treatments: at potentially great cost to the world.
Moves by Moderna and BioNTech to make vaccines themselves in African countries signal that the companies aren’t considering licensing its technology to a third party for local manufacture.
In the two years since COVID was declared a pandemic, vaccines and treatments have been rapidly developed – yet millions worldwide have died.
Only one in three of the children in our research project did their schoolwork on a laptop or computer.
Decreases in respiratory infections during the pandemic suggest there may be a continued role for the selective, non-mandated use of measures like masks and social distancing even post-COVID-19.
Progress against neglected tropical diseases is now at real risk of reversal as a result of the COVID-19 pandemic.
A highlight of this pandemic is how quickly effective vaccines were developed and rolled out.
It’s a huge cause for concern that, two years into the pandemic, the disparities and unequal power structures in global health are still intact.
By altering the body’s internal clock, ‘springing forward’ may contribute to an increase in heart attacks and strokes.
As COVID-19 survivors join the ranks of people with disabilities, they could have a long wait to get the support they need.
COVID has disrupted how we work, socialise and shop, but there are some signs we’re returning to doing things like we used to.
The mud rarely sticks.
Making daily time to connect with their children is an important way of nurturing family experiences and relationships and to find restoration.
Public scorn in response to a news story about how to cope with stressful news ignores a fact: The news can take a mental and psychological toll on a person.
We asked over 1,000 people whether the lifting of restrictions in England signals the end of the pandemic – the majority thought it didn’t.
Most people with COVID will recover at home without any treatment. But some people who are at risk of severe disease could benefit from new medicines to reduce the chance of the disease progressing.
The drug has been authorised for the use in the UK and elsewhere, but some are calling for further testing.
New research offers insights into the brain after COVID-19 that may have implications for our understanding of long COVID-19 and how the disease affects our senses of taste and smell.
Brain changes including shrinkage, weakened connections and poorer performance on thinking and memory tests could explain ‘brain fog’ after COVID – even after ‘mild’ cases.
Top contributors
-
Professorial Fellow, University of Canberra
-
Associate Professor, Epidemiology, Deakin University
-
Professor of Economics, UNSW Sydney
-
Chair in Epidemiology, Deakin University
-
Professor of Global Biosecurity, NHMRC L3 Research Fellow, Head, Biosecurity Program, Kirby Institute, UNSW Sydney
-
Professor of Biostatistics and Epidemiology, University of South Australia
-
Honorary Enterprise Professor, School of Population and Global Health, and Department of General Practice and Primary Care, The University of Melbourne
-
Senior Research Fellow in Global Health, University of Southampton
-
Visiting Fellow, Crawford School of Public Policy, Australian National University
-
Dean Faculty of Health Sciences and Professor of Vaccinology at University of the Witwatersrand; and Director of the SAMRC Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand
-
Professor of Medicine, University of East Anglia
-
Associate Professor, School of Population Health, UNSW Sydney
-
Professor of Medicine, University of Virginia
-
Professor of Public Health, University of Sheffield
-
Associate Professor of Bioethics, University of Portsmouth
